Platinum-based chemotherapy for variant castrate-resistant prostate cancer.

@article{Aparicio2013PlatinumbasedCF,
  title={Platinum-based chemotherapy for variant castrate-resistant prostate cancer.},
  author={Ana Aparicio and Andrea Lynne Harzstark and Paul G. Corn and Sijin Wen and John Charles Araujo and Shi-ming Tu and Lance C. Pagliaro and Jeri Kim and Randall E. Millikan and Charles T. Ryan and Nizar M. Tannir and Amado J. Zurita and Paul Mathew and Wadih Arap and Patricia Carolina Alvarez Troncoso and Peter F. Thall and Christopher J. Logothetis},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2013},
  volume={19 13},
  pages={
          3621-30
        }
}
PURPOSE Clinical features characteristic of small-cell prostate carcinoma (SCPC), "anaplastic," often emerge during the progression of prostate cancer. We sought to determine the efficacy of platinum-based chemotherapy in patients meeting at least one of seven prospectively defined "anaplastic" clinical criteria, including exclusive visceral or predominantly lytic bone metastases, bulky tumor masses, low prostate-specific antigen levels relative to tumor burden, or short response to androgen… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 90 CITATIONS, ESTIMATED 44% COVERAGE

Neuroendokrines Prostatakarzinom

VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Neuroendokrines Prostatakarzinom

VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Neuroendocrine prostate cancer after hormonal therapy: knowing is half the battle.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2014
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2016
VIEW 3 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2016
VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2011
2019

CITATION STATISTICS

  • 14 Highly Influenced Citations

  • Averaged 12 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 46 REFERENCES

Treatment of patients with small-cell lung cancer: frommeta-analyses to clinical practice

A Rossi, O Martelli, M. Di Maio
  • Cancer Treat Rev 2013;39:498–506
  • 2013
VIEW 2 EXCERPTS

Modeling a lethal prostate cancer variant with small-cell carcinoma features.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2012
VIEW 2 EXCERPTS